|
1
|
Wittig JC, Bickels J, Priebat D, Jelinek
J, Kellar-Graney K, Shmookler B and Malawer MM: Osteosarcoma: A
multidisciplinary approach to diagnosis and treatment. Am Fam
Physician. 65:1123–1132. 2002.PubMed/NCBI
|
|
2
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Link MP, Goorin AM, Miser AW, Green AA,
Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick
JA, et al: The effect of adjuvant chemotherapy on relapse-free
survival in patients with osteosarcoma of the extremity. N Engl J
Med. 314:1600–1606. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meyers PA, Healey JH, Chou AJ, Wexler LH,
Merola PR, Morris CD, Laquaglia MP, Kellick MG, Abramson SJ and
Gorlick R: Addition of pamidronate to chemotherapy for the
treatment of osteosarcoma. Cancer. 117:1736–1744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanahan D and Coussens LM: Accessories to
the crime: Functions of cells recruited to the tumor
microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taki M, Abiko K, Ukita M, Murakami R,
Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N and Mandai
M: Tumor immune microenvironment during epithelial-mesenchymal
transition. Clin Cancer Res. Apr 7–2021.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu MH, Bauman EM, Roll RL, Yeilding N and
Abrams CS: Pleckstrin 2, a widely expressed paralog of pleckstrin
involved in actin rearrangement. J Biol Chem. 274:21515–21518.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Naume B, Zhao X, Synnestvedt M, Borgen E,
Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G,
Kåresen R, et al: Presence of bone marrow micrometastasis is
associated with different recurrence risk within molecular subtypes
of breast cancer. Mol Oncol. 1:160–171. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo Y, Robinson S, Fujita J, Siconolfi L,
Magidson J, Edwards CK, Wassmann K, Storm K, Norris DA,
Bankaitis-Davis D, et al: Transcriptome profiling of whole blood
cells identifies PLEK2 and C1QB in human melanoma. PLoS One.
6:e209712011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen H, He M, Lin R, Zhan M, Xu S, Huang
X, Xu C, Chen W, Yao Y, Mohan M and Wang J: PLEK2 promotes
gallbladder cancer invasion and metastasis through EGFR/CCL2
pathway. J Exp Clin Cancer Res. 38:2472019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sadikovic B, Yoshimoto M, Chilton-MacNeill
S, Thorner P, Squire JA and Zielenska M: Identification of
interactive networks of gene expression associated with
osteosarcoma oncogenesis by integrated molecular profiling. Hum Mol
Genet. 18:1962–1975. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fritsche-Guenther R, Noske A, Ungethüm U,
Kuban RJ, Schlag PM, Tunn PU, Karle J, Krenn V, Dietel M and Sers
C: De novo expression of EphA2 in osteosarcoma modulates activation
of the mitogenic signalling pathway. Histopathology. 57:836–850.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuijjer ML, Rydbeck H, Kresse SH, Buddingh
EP, Lid AB, Roelofs H, Bürger H, Myklebost O, Hogendoorn PC,
Meza-Zepeda LA and Cleton-Jansen AM: Identification of osteosarcoma
driver genes by integrative analysis of copy number and gene
expression data. Genes Chromosomes Cancer. 51:696–706. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Laferriere CA and Pang DS: Review of
intraperitoneal injection of sodium pentobarbital as a method of
euthanasia in laboratory rodents. J Am Assoc Lab Anim Sci.
59:254–263. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ge X, Liu W, Zhao W, Feng S, Duan A, Ji C,
Shen K, Liu W, Zhou J, Jiang D, et al: Exosomal transfer of LCP1
promotes osteosarcoma cell tumorigenesis and metastasis by
activating the JAK2/STAT3 signaling pathway. Mol Ther Nucleic
Acids. 21:900–915. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kong Y, Wu R, Zhang S, Zhao M, Wu H, Lu Q,
Fu S and Su Y: Wilms' tumor 1-associating protein contributes to
psoriasis by promoting keratinocytes proliferation via regulating
cyclinA2 and CDK2. Int Immunopharmacol. 88:1069182020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin L, Xiao J, Shi L, Chen W, Ge Y, Jiang
M, Li Z, Fan H, Yang L and Xu Z: STRA6 exerts oncogenic role in
gastric tumorigenesis by acting as a crucial target of miR-873. J
Exp Clin Cancer Res. 38:4522019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu W, Jiang D, Gong F, Huang Y, Luo Y,
Rong Y, Wang J, Ge X, Ji C, Fan J and Cai W: miR-210-5p promotes
epithelial-mesenchymal transition by inhibiting PIK3R5 thereby
activating oncogenic autophagy in osteosarcoma cells. Cell Death
Dis. 11:932020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen T, Wang W, Zhou W, Coleman I, Cai Q,
Dong B, Ittmann MM, Creighton CJ, Bian Y, Meng Y, et al: MAPK4
promotes prostate cancer by concerted activation of androgen
receptor and AKT. J Clin Invest. 131:e1354652021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bakir B, Chiarella AM, Pitarresi JR and
Rustgi AK: EMT, MET, plasticity, and tumor metastasis. Trends Cell
Biol. 30:764–776. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng HC, Chang TK, Su WC, Tsai HL and
Wang JY: Narrative review of the influence of diabetes mellitus and
hyperglycemia on colorectal cancer risk and oncological outcomes.
Transl Oncol. 14:1010892021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang J, Xu Y, Ren H, Wudu M, Wang Q, Song
X, Su H, Jiang X, Jiang L and Qiu X: MKRN2 inhibits migration and
invasion of non-small-cell lung cancer by negatively regulating the
PI3K/Akt pathway. J Exp Clin Cancer Res. 37:1892018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim EH, Kim MS, Lee KH, Sai S, Jeong YK,
Koh JS and Kong CB: Effect of low- and high-linear energy transfer
radiation on in vitro and orthotopic in vivo models of osteosarcoma
by activation of caspase-3 and −9. Int J Oncol. 51:1124–1134. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Biermann JS, Adkins DR, Agulnik M,
Benjamin RS, Brigman B, Butrynski JE, Cheong D, Chow W, Curry WT,
Frassica DA, et al: Bone cancer. J Natl Compr Canc Netw.
11:688–723. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bach TL, Kerr WT, Wang Y, Bauman EM, Kine
P, Whiteman EL, Morgan RS, Williamson EK, Ostap EM, Burkhardt JK,
et al: PI3K regulates pleckstrin-2 in T-cell cytoskeletal
reorganization. Blood. 109:1147–1155. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hamaguchi N, Ihara S, Ohdaira T, Nagano H,
Iwamatsu A, Tachikawa H and Fukui Y: Pleckstrin-2 selectively
interacts with phosphatidylinositol 3-kinase lipid products and
regulates actin organization and cell spreading. Biochem Biophys
Res Commun. 361:270–275. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ombrato L and Malanchi I: The EMT
universe: Space between cancer cell dissemination and metastasis
initiation. Crit Rev Oncog. 19:349–361. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Smith BN and Bhowmick NA: Role of EMT in
metastasis and therapy resistance. J Clin Med. 5:172016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Y, Sarkissyan M and Vadgama JV:
Epithelial-mesenchymal transition and breast cancer. J Clin Med.
5:132016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chaki SP, Barhoumi R, Berginski ME,
Sreenivasappa H, Trache A, Gomez SM and Rivera GM: Nck enables
directional cell migration through the coordination of polarized
membrane protrusion with adhesion dynamics. J Cell Sci.
126:1637–1649. 2013.PubMed/NCBI
|
|
35
|
Lafuente EM, van Puijenbroek AA, Krause M,
Carman CV, Freeman GJ, Berezovskaya A, Constantine E, Springer TA,
Gertler FB and Boussiotis VA: RIAM, an Ena/VASP and profilin
ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion.
Dev Cell. 7:585–595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Krause M, Leslie JD, Stewart M, Lafuente
EM, Valderrama F, Jagannathan R, Strasser GA, Rubinson DA, Liu H,
Way M, et al: Lamellipodin, an Ena/VASP ligand, is implicated in
the regulation of lamellipodial dynamics. Dev Cell. 7:571–583.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tscharntke M, Pofahl R, Krieg T and Haase
I: Ras-induced spreading and wound closure in human epidermal
keratinocytes. FASEB J. 19:1836–1838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: A play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ediriweera MK, Tennekoon KH and Samarakoon
SR: Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer:
Biological and therapeutic significance. Semin Cancer Biol.
59:147–160. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hoxhaj G and Manning BD: The PI3K-AKT
network at the interface of oncogenic signalling and cancer
metabolism. Nat Rev Cancer. 20:74–88. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Porta C, Paglino C and Mosca A: Targeting
PI3K/Akt/mTOR signaling in cancer. Front Oncol. 4:642014.
View Article : Google Scholar : PubMed/NCBI
|
